The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)

Lung cancer is the leading cause of death by cancer in North America. A decade ago, genomic rearrangements in the anaplastic lymphoma kinase (ALK) receptor tyrosine kinase were identified in a subset of non-small cell lung carcinoma (NSCLC) patients. Soon after, crizotinib, a small molecule ATP-comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Golding, Brandon, Luu, Anita, Jones, Robert, Viloria-Petit, Alicia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817728/
https://www.ncbi.nlm.nih.gov/pubmed/29455675
http://dx.doi.org/10.1186/s12943-018-0810-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817728/
https://www.ncbi.nlm.nih.gov/pubmed/29455675
http://dx.doi.org/10.1186/s12943-018-0810-4

Ejemplares similares